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Abstract  15 
Objectives: Hyperoxia (> 21% oxygen) can evoke performance improvements in aerobic and 16 
anaerobic exercise. The aims of the current study were to determine the effects of breathing 17 
hyperoxic gas (fraction of inspired oxygen [FiO2] 1.00) on repeated cycle performance, and to 18 
assess the nature and extent of fatigue after intermittent sprinting. 19 
Design & Methods: Testing (n=14 males) comprised two visits to the laboratory. Each 20 
session involved 10 x 15s repeated cycle sprints breathing FiO2 1.00 (hyperoxia) or FiO2 0.21 21 
(normoxia). Muscle fatigue was measured pre and post sprints using maximal voluntary 22 
contraction (MVC), voluntary activation (VA) and potentiated doublet twitch (PTF). Blood 23 
lactate (BLa) was taken between sprints. 24 
Paired samples t-tests were used to examine difference between conditions in power output 25 
(peak and mean Watts) and BLa. Two-way ANOVA was used to examine fatigue variables 26 
pre and post sprints according to condition.  27 
Results: Mean power output was 4% greater in hyperoxia (p<0.01), with no difference in peak 28 
power (p>0.05). There was a significant increase in BLa in hyperoxia compared with normoxia 29 
(p<0.01) in sprints 4 and 8, as well as meaningful difference in sprints 4-10. There was no 30 
significant difference in fatigue factors (MVC, VA and PTF) (p>0.05) in response to the cycling, 31 
although a large drop in PTF occurred in both conditions. 32 
Conclusion: Hyperoxia can elicit improvements in mean cycling power, with no significant 33 
change in post exercise muscle fatigue. Hyperoxia as a training aid may provide performance 34 
enhancing effects during repeated sprint cycling by reducing concurrent muscle fatigue, 35 
primarily via peripheral factors.  36 
Keywords: Oxygen, Power, Lactate, Training, Sprinting. 37 
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 Introduction 38 
Hyperoxia is the inhalation of air with a fraction of inspired oxygen (FiO2) greater than that of 39 
sea level (20.9%). Supplementing high intensity exercise with FiO2 >0.21 allows the 40 
maintenance of performance when fatigue would usually become apparent, both during 41 
aerobic and sprint exercise 1,2.  The mechanism behind this attenuation of performance decline 42 
are multifactorial and include  reduced production of blood lactate (BLa)1, enhanced clearance 43 
of BLa, prevention of muscle oxygen desaturation3,4 the maintenance of blood pH  and 44 
enhanced resynthesis of creatine phosphate 5. These factors are associated with peripheral 45 
fatigue; i.e. the exercise induced decrease in muscle force production.  46 
A reduction in neural drive from the motor cortex to muscle appears as a decrease in voluntary 47 
muscle activation (VA) during exercise6. This ‘central fatigue’, may also be influenced by the 48 
fraction of inspired air. Indeed, research has shown that a reduced cerebral O2 delivery 49 
resulting from hypoxia (FiO2 0.18) results in curtailment of exercise performance due to 50 
fatigue7. Thus, whether hyperoxia can alleviate central fatigue in a sport situation is unknown.  51 
Performance decline is likely a combination of both central and peripheral factors and the 52 
relative contribution of each depends upon the nature of the task 8. Peripheral fatigue is likely 53 
the limiting factor in short, high intensity exercise, with central fatigue playing a greater role as 54 
the exercise bout continues. For example, a single 4 km time trial lasting around 5 minutes 55 
was shown to be limited by peripheral fatigue, whilst a 20 km trial (lasting around 32 minutes) 56 
was primarily limited by central fatigue8.  57 
Repeated sprint efforts represent a short term high intensity exercise, which are likely to be 58 
limited primarily by peripheral fatigue 9. However, the extent to which central fatigue 59 
contributes to performance decline in repeated sprint performance is equivocal. Racinais et 60 
al., 10 determined that the ability to repeat short duration sprints was associated with both 61 
central and peripheral factors. The twitch interpolation technique is widely used and is 62 
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considered a reliable method to estimate the origin of neuromuscular fatigue. Peripheral 63 
fatigue is measured by comparing the force responses to electrical stimulation pre and post 64 
fatiguing exercise. To determine the contribution of central factors the twitch interpolation 65 
technique is used, superimposing single or double twitches on MVC then comparing the 66 
superimposed response to the potentiated response obtained from the relaxed muscle 67 
Thus, the aims of the current study were to determine the effects of hyperoxia on repeated 68 
cycle performance, and to assess the nature and extent of fatigue after sprinting. 69 
It was hypothesised that repeated sprint cycle performance would decrease to a larger degree 70 
in the normoxia condition compared with the hyperoxia condition.  Second, it was 71 
hypothesised that both central and peripheral components of fatigue would be reduced to a 72 
greater extent in the normoxia condition.   73 
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Methods  74 
Fourteen healthy males were recruited to take part in the study. Participants (1.81 ± 0.04 m, 75 
77.6 ± 11.0 kg, 25.9 ± 7.3 years) were recreational cyclists who had all previously used a cycle 76 
ergometer. Participants were accustomed to cycling on a weekly basis, but none had ever 77 
competed at any cycling events. 78 
Participants were informed of the procedure and provided informed consent. Ethical approval 79 
for the study was granted by the University ethics committee.  80 
This study was a within subjects design with 2 visits to the laboratory in a counter balanced 81 
order, in a single blind fashion. Participants completed a series of sprints under two different 82 
conditions; hyperoxia (FiO2 ~ 1.00) or normoxia (FiO2 ~ 0.21). Visits were separated by at 83 
least 48hrs. 84 
Laboratory tests were completed at the same time of the day (±2h). Participants were asked 85 
to maintain normal activity and sleep patterns between testing sessions. Participants were 86 
requested to refrain from any caffeinated products or eating three hours prior to participation. 87 
Participants were asked to refrain from strenuous physical activity 24 hours prior to 88 
participating. 89 
Participants undertook the same procedure on both visits; 3x5s Maximal Voluntary 90 
Contractions (MVC) then 15 minute relative intensity warm up at 52% of heart rate reserve 91 
using the rearranged  Karvonen formula 11,12 . This was followed by 10-minute passive 92 
recovery, 3x5s MVCs (pre-sprint baseline) and 10x15s cycle sprints with 45 seconds of 93 
recovery. Finally, a further set of 3x5s MVCs (post-sprint). Gas administration occurred at 94 
the commencement of the first sprint and continued throughout the sprints and the post 95 
sprint MVC’s. 96 
Hyperoxic and normoxic gas mixtures were administered via a rig of 4 x 200 L Douglas bags 97 
connected to a mask and head net (Hans Rudolph, Shawnee, KS, USA). The hyperoxia 98 
condition used medical grade oxygen (BOC, Surrey, UK). In each condition, participants wore 99 
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the mask and breathed from the Douglas bag during the repeated sprints and the last set of 100 
MVC’s.  101 
Prior to starting the protocol, a pre-exercise 20 µl capillary sample was taken from the right 102 
ear lobe. Each sample was mixed with haemolysing solution within a 0.5 ml haemolysing 103 
solution cup. Further samples were taken during the recovery period of each sprint repetition. 104 
All samples were analysed for blood lactate within 24 hours of withdrawal using a Biosen (EKF 105 
diagnostics, Cardiff, UK). 106 
Muscle fatigue was assessed prior to and after the repeated sprints using electrical stimulation 107 
of the right femoral nerve. The right leg was used regardless of dominance due to 108 
measurement restraints. The variables obtained to assess muscle performance were; 109 
maximal voluntary contraction (MVC), voluntary activation (VA) and potentiated doublet twitch 110 
force (PTF).  Muscle fatigue was measured within 1 minute of exercise cessation before the 111 
decline in force dissipates 13. 112 
Knee extensor force (N) during voluntary and stimulated contractions was measured using a 113 
calibrated load cell dynamometer (Kin-Com, Chattanooga Group Inc., USA), attached to a 114 
custom-built chair. The participant’s ankle was strapped to a load cell immediately superior to 115 
the right malleoli. Participants were instructed to maximally extend their leg against a static 116 
load cell at 90° for 5 seconds. Femoral nerve stimulation was delivered during the middle of 117 
each contraction and additionally ~5s after contraction, to determine potentiated quadriceps 118 
twitch force and peripheral voluntary activation. PTF was measured as the highest force 119 
produced during the three repetitions evoked by a paired pulse stimulus, administered to the 120 
resting muscle via the nerve at rest, 5 seconds post the MVC14. VA was determined using the 121 
interpolated doublet twitch technique and is estimated by the changes in the interpolated 122 
doublet twitch relative to the PTF (equation1). The force evoked by the imposed electrical 123 
stimulus on top of the MVC is the interpolated doublet twitch (IT). 124 
Eq 1. Determining voluntary activation 15. 125 
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Doublet- twitch electrical stimuli of 200µs pulse width were delivered to the right femoral nerve 128 
via surface electrodes (Axelgaard ValuTrode) and a constant current stimulator (DS7AH; 129 
Digitimer Ltd., Welwyn Garden City, UK). A signal converter was used to convert the digital 130 
signals of the computer to analogue signals of the digitimer with a sampling rate of 2000 Hz 131 
(PowerLab/4st – ML760, AD Instruments, UK). The cathode was positioned on the femoral 132 
triangle. The anode was positioned 3cm proximal to the base of the patella, whilst the knee 133 
was fully flexed16. Prior to application of the pads, the area was shaven. The electrode 134 
placement was marked with semi-permanent ink to ensure consistent placement between 135 
trials.  136 
 137 
Prior to the MVCs, participants completed resting twitch stimuli in order to determine the 138 
maximal twitch amplitude and M-wave of the muscle at rest (the resting immediate response 139 
to an electrical stimulation). Doublet twitch stimuli were delivered starting at 100mA and 140 
increasing to 150mA then increasing in stepwise increments of 25mA, until a plateau occurred 141 
in twitch amplitude. To ensure a full and optimal stimulus the last twitch was increased by a 142 
further 30%.  Offline analysis was enabled with the use of LabChart 7.0 software (AD 143 
Instruments, UK).   144 
 145 
Following the warm up and two sets of MVCs each participant undertook 10 repetitions of 15 146 
second cycling sprint (Watt Bike, Nottingham, UK) followed by 45 sec static recovery. 147 
Participants were instructed to stay seated to isolate leg power. The air brake was set to 10 148 
and magnetic brake set to one to allow sufficient resistance to generate peak force, whilst not 149 
exceeding peak cadence. During each sprint and recovery period the participants breathed 150 
either normoxic or hyperoxic air via the Douglas bag system. Data used for analysis were peak 151 
sprinting power (the highest W achieved in each cycle) and mean sprint power (the average 152 
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W produced during each 15 sec cycle). An overall peak and an overall mean were also 153 
calculated for each participant. 154 
 155 
All statistical analysis was performed using the statistical package, SPSS statistics version 25 156 
for windows (SPSS Inc, Chicago, IL, USA). 157 
Paired samples t-tests (Bonferroni corrected) were conducted to examine differences 158 
according to condition (hyperoxia / normoxia) for; peak power (W), mean power (W) across 159 
each 15 second sprint, and blood lactate (mmol/L) for each sprint. Two-way analysis of 160 
variance (ANOVA) were conducted to test the differences between MVC, VA, PT before and 161 
after the repeated sprints, according to condition. Alpha was set at p = 0.05 for all data 162 
analysis. Effect size for individual measures were calculated and reported as Cohen’s d and 163 
interpreted using bounds as 0.2, 0.5, > 0.8, where they are small, medium and large 164 
respectively17. 165 
  166 
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Results 167 
There was no difference in peak sprinting power (W) between the hyperoxia (753.3 ± 87.8) 168 
and normoxia (761.0 ± 97.4) conditions across the 10 sprint repetitions; t (9) = 1.09, p =0.304, 169 
ES = -0.08. However, average power was significantly higher (around 25W) in the hyperoxia 170 
condition (654.6 ± 86.9) compared with the normoxia condition (629.2 ± 96.2) across the 10 171 
sprint repetitions; t (9) = -4.65, p= 0.001, ES = 0.28 (figure 1). 172 
Mean blood lactate was higher in the hyperoxia condition (9.81 mmol/L), although only by a 173 
small margin (0.43 mmol/L) t (9) = 3.36, p=0.008, ES = -0.13. When comparing sprints directly 174 
between conditions, it was only after sprints 4 and 8 that this difference reached significance 175 
(figure 2). 176 
MVC : As expected there was a main effect of time on muscle force, (F(1,12)=34.47, 177 
p<0.001, ES = 4.14) with a decrease in MVC post the sprints (pre 774.4 ± 46.3 vs post 587.9 178 
± 43.7) Despite a somewhat larger decline in MVC  in the hyperoxia trial, there was no 179 
statistical difference between conditions (p=0.66,) (table 1). There was no interaction effect 180 
for condition x time (p=0.08)  181 
PTF: Again a main effect was found for time (F(1,12)=53.03, p<0.001, ES = 8.66) with a 182 
smaller potentiated doublet twitch production post sprints compared to pre-sprint (pre 459.2 183 
± 22.2 vs post 290.4 ± 16.5), but not for condition  (p=0.86, ES = -0.03). There was no 184 
interaction effect reported for condition x time (p=0.31) for PTF. 185 
VA: A main effect was found for condition (F(1,12)=8.23, p=0.013, ES = 2.23) with a higher 186 
voluntary activation in hyperoxia compared with normoxia (79.1 ± 2.2 vs 74.3 ± 2.1 187 
respectively),  but no effect of time (p=0.14). Importantly there was no interaction effect 188 
reported for condition x time (p=0.79) for VA. 189 
 190 
  191 
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Discussion  192 
 193 
The aim of this study was to identify the effects of hyperoxia on repeated sprint ability and 194 
begin to examine its effects on muscle fatigue using interpolated twitch. Though peak cycling 195 
power was not different between conditions, average power was higher in the hyperoxia trials, 196 
by around 4%, indicating that a higher work output could be maintained in the presence of 197 
extra oxygen. This higher mean power was associated with a higher blood lactate level. There 198 
was no significant effect of condition on changes in muscle fatigue measures (assessed by 199 
MVC and electrical stimulation). 200 
 201 
The current study found that breathing hyperoxic air during 15 second repeated sprint efforts 202 
led to a higher mean power output, (around 25 Watts), with no significant influence on peak 203 
power. Hauser et al.,18 found that mean power was not different between the two conditions 204 
in their study (FiO2=1.00 and FiO2=0.21). However, their methodology of 3 x 3-minute sprints 205 
meant their participants were potentially predominately using a different energy system to that 206 
used in a 15 second sprint. The lactic acid system and the aerobic system are the predominate 207 
sources of ATP production during maximal 3-minute efforts, whereas the during 15 second 208 
sprints the majority of ATP is supplied by the ATP-PC system. Second, Hauser’s participants 209 
experienced hyperoxia between efforts only. Timing of hyperoxia is potentially key. For 210 
example, Sperlich et al 19 also report no difference in mean or peak power across 2 sets of 5 211 
x 30 sec cycle sprints. Although nature of the exercise was more similar to the current study, 212 
in contrast, their participants only had supplementary oxygen in the 6-minute recovery period 213 
between sets of cycle sprints.  214 
 215 
Hyperoxia has been shown to attenuate the onset of fatigue at a peripheral level whilst also 216 
maintaining cerebral oxygenation 20. In the current study, MVC, a global measure of fatigue, 217 
dropped by around 20% in the normoxia condition, and by around 28% in the hyperoxia 218 
condition. This shows that there was greater (albeit non-significant) muscle fatigue as a result 219 
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of the higher mean power output in the hyperoxia condition. Interestingly, the change in PTF 220 
and %VA were broadly similar across conditions. The drop in voluntary activation (%) was 221 
small and less than 1.5% different between conditions. The drop in PTF however was large, 222 
although again similar between conditions (34 and 38%, Table 1). These results support the 223 
findings of Thomas et al 8, who report performance in shorter efforts is predominately curtailed 224 
by peripheral measures.  225 
 226 
The ability to maintain power throughout repeated efforts has been attributed to several factors 227 
including the ability to maintain BLa, regulate pH, to maintain neural input21 and importantly, 228 
to replenish phosphocreatine (PC) stores. According to Linossier et al., 1 sprint capacity is not 229 
reduced to the same extent in hyperoxia due to the increased rate of cellular metabolic 230 
resynthesis of PC, and adenosine triphosphate (ATP). PC resynthesis during 45 seconds of 231 
recovery only replenishes ~75% of the stores 22. Therefore, after sprint 5 in a series such as 232 
this one would expect to see a significant performance reduction. A continued depletion of 233 
ATP-PC stores and an inadequate resynthesis leads to a reduction in performance until 234 
additional energy systems aid in the resynthesis process (lactic acid system). An increase in 235 
peak and mean power has been attributed to an enhanced PC resynthesis during repeated 236 
high intensity exercise by both Mendez- Villanueva et al.,23 , and Glaister,22. Mendez- 237 
Villanueva analysed PC recovery rate during 10 x 6s sprints with 30 seconds recovery and 238 
found that subsequent sprinting performance (peak power) during a final single sprint was 239 
increased corresponding with an 8% higher PC resynthesis.  240 
 241 
Increasing the percentage of inspired oxygen to 100% increases the rate of PC replenishment 242 
from a half-life of 25 seconds to 20 seconds24,25. Hogan et al.,24 used a plantar flexion exercise 243 
protocol with increasing workload till exhaustion. They found that an increased rate of PC 244 
resynthesis aided subsequent performance, and that hyperoxia maintained mean plantar 245 
flexion power further into the ramp test protocol (1W increase every 2 minutes by pulley 246 
system). This findings was replicated in the current study as mean sprinting power during 247 
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hyperoxia was similar to that during normoxia until sprint 4 and beyond where the difference 248 
became statistically significant. Additionally, sprint 6 was where peak power in the normoxic 249 
group appeared to decline at a greater rate than the hypoxia condition. Sprint 6 in a typical 250 
series is where it has been documented the reliance on aerobic metabolism increases 22.  251 
 252 
Interestingly, the increase in sprint performance as a result of hyperoxia was similar to that 253 
seen with creatine supplementation, likely through the same mechanisms of PC resynthesis 254 
22. Additional to this enhanced rate of resynthesis, hyperoxia has been shown to attenuate the 255 
build-up of metabolic by products of lactate, and inorganic phosphate (Pi)26. Pi in particular is 256 
detrimental to performance via inhibition of muscle afferents. Type III and IV muscle afferents 257 
relay exercise induced metabolic changes in the muscles to the central nervous system. The 258 
accumulation of metabolic by-products reduces the effectiveness of these afferents, 259 
subsequently leading to peripheral fatigue. However, both afferents are positively influenced 260 
by hyperoxia, by allowing the electrical feedback to be transmitted efficiently for longer26, so 261 
attenuating fatigue. 262 
 263 
Hyperoxia elicits reductions in blood lactate at many workloads 1,27 and although hyperoxia 264 
given during recovery periods attenuates lactate accumulation, the effects are more variable. 265 
3. Maeda et al., gave varying percentages of hyperoxia (30 to 100%) in the recovery between 266 
sprints, and found that whilst overall increasing the fraction of oxygen resulted in reduced 267 
blood lactate after standardised exercise, the response was dependent on the subjects’ 268 
fitness. In the current study, higher power outputs seen in the hyperoxia condition were 269 
associated with slightly increased lactate levels. Knight et al.,28 suggest that the increase in 270 
oxygen kinetics during hyperoxia is enough to attenuate the accumulation of lactate due to the 271 
increased diffusion of oxygen into the mitochondria. However, they add that that this 272 
attenuation can only last so long, and after a critical point lactate levels will increase 273 
exponentially. This could explain the increases in lactate that have been seen in the current 274 
study. 275 
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 276 
Therefore, it is suggested that hyperoxia results in a combination of increased PC resynthesis 277 
and a slightly attenuated build-up of blood lactate, leading to a ‘maintained’ performance 278 
compared to the normoxia condition seen in the current study. Acute exposure to additional 279 
oxygen appears to enhance repeated sprint performance, however, determining whether 280 
chronic physiological adaptation is blunted is crucial before its widespread use as a training 281 
tool can be advised. 282 
 283 
Limitations 284 
We acknowledge several limitations of this study. Participants were required to avoid 285 
strenuous exercise 24hrs prior to testing but it is noted that the effects of training may be 286 
evident for 48/72 hrs. To minimise the effects of this, participants were requested to mimic the 287 
training three days prior to testing before both visits. Further, no direct measure of fitness (V̇O2 288 
max) was conducted to characterise the study population. Level of fitness is a potential 289 
mediator of response to hyperoxia. Additionally, hydration status was not measured prior to 290 
testing, but participants were instructed to attend testing in a hydrated state.  291 
 292 
Conclusion   293 
Whilst supplementary oxygen does not increase peak power during repeated sprints, 294 
participants were able to maintain a higher mean power output (across the 10 sprints). Indices 295 
of fatigue (MVC, PFT and VA) changed to a similar extent across conditions in response to 296 
the cycling, but the largest drop was in PFT, suggesting fatigue to be predominately peripheral 297 
in nature.  298 
 299 
Practical implications 300 
- Supplementary oxygen given during a single sprint-based cycling session can assist 301 
in reducing the extent that performance decreases.  302 
- Peak power output cannot be increased with supplementary oxygen 303 
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- Long term effects of the use of oxygen during training are not known and therefore its 304 
use as a chronic training tool is not yet advised 305 
 306 
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Table 1: Neuromuscular function of the knee extensors; Maximal Voluntary contraction 382 
(MVC), potentiated doublet twitch (PTF) and voluntary activation (VA) (n = 14). 383 
 Normoxia Hyperoxia 
 Pre-Sprint Post Sprints % 
Difference 




762.6 ± 169.1 611.3 ± 150.6 19.8 786.1 ± 187.0 564.4 ± 204.6 28.2 
PTF (N) 452.1 ± 86.0 295.4 ± 64.0 34.6 466.2 ± 95.5 285.4 ± 67.4 38.8 






Figure 1. Mean sprinting power across 10 sprints (n = 14). * significant difference 389 





Figure 2. Mean blood lactate concentration (mmol/L) over 10 sprints (n = 14). * 395 
significant difference between condition (Hyperoxia and normoxia) (p< 0.05). 396 
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Supplementary Table 397 
Table 1. Mean ± SD and Cohens D effect Sizes for three variables in each condition for each of the 10 repeat cycling sprints (n =14).  398 
Sprint No. One Two Three Four Five Six Seven Eight Nine Ten 
Mean Power           
Normoxia 842.46 ± 105.17 724.96 ± 92.88 685.49 ± 98.34 634.51 ± 103.25 606.80 ± 110.01 564.59 ± 111.96 558.25 ± 103.31 541.18 ± 104.65 557.90 ± 99.21 575.75 ± 115.21 
Hyperoxia 828.89 ± 139.45 770.36 ± 129.76 696.71 ± 110.11 671.37 ± 125.76 632.03 ± 120.82 592.14 ± 120.60 579.30 ± 115.21 585.90 ± 104.63 588.79 ± 107.63 600.38 ± 119.93 
ES -0.11 0.40 0.11 0.32 0.22 0.24 0.19 0.43 0.30 0.21 
           
Peak Power           
Normoxia 958.29 ± 120.03 862.57 ± 109.61 835.79 ± 99.77 776.29 ± 111.79 732.36 ± 113.37 699.14 ± 128.97 680.79 ± 106.48 655.62 ± 115.01 674.42 ± 114.36 734.83 ± 148.52 
Hyperoxia 921.27 ± 115.22 870.99 ± 88.89 798.44 ± 96.66 786.48 ± 142.55 730.92 ± 124.85 684.57 ± 150.55 673.17 ± 137.09 678.97 ± 132.18 687.38 ± 124.47 921.27 ± 133.62 
ES -0.31 0.08 -0.38 0.08 -0.01 -0.10 -0.06 0.19 0.11 1.32 
           
Blood lactate           
Normoxia 3.05 ± 1.64 5.02 ± 1.57 7.08 ± 2.86 8.44 ± 2.68 10.14 ± 3.18 10.74 ± 3.28 11.98 ± 3.79 12.47 ± 3.80 12.00 ± 3.50 12.85 ± 3.30 
Hyperoxia 2.87 ± 0.59 5.36 ± 1.74 7.48 ± 2.01 9.50 ± 2.33 10.57 ± 3.31 11.34 ± 3.09 12.28 ± 2.75 12.79 ± 2.55 13.10 ± 2.68 12.81 ± 2.93 
ES -0.15 0.21 0.16 0.42 0.14 0.19 0.09 0.10 0.35 -0.01 
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